Permanent Diffuse Alopecia After Hematopoietic Stem Cell Transplantation in Childhood

March 2017 in “ Bone Marrow Transplantation ”

Dorine Bresters, Dominique C.M. Wanders, Marloes Louwerens, Lynne M. Ball, M. Fiocco, Remco van Doorn

Studysummary In this study, permanent alopecia after haematopoietic stem cell transplantation was found in 16% of patients and was significantly associated with conditioning regimens involving busulphan.

Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer

View this study on nature.com →

Discuss this study in the Community →

Research cited in this study

9 / 9 results

research Risk Factors and Characterization of Vitiligo and Alopecia Areata in Patients With Chronic Graft-Versus-Host Disease

27 citations , September 2014 in “JAMA dermatology”

In this NIH study, female donor to male recipient sex mismatch was significantly associated with the development of vitiligo and/or alopecia areata in patients with chronic graft-vs-host disease.

research Pathobiology of Chemotherapy-Induced Hair Loss

218 citations , January 2013 in “The Lancet Oncology”

This review discusses the pathobiology of chemotherapy-induced alopecia and highlights challenges in managing it, reporting no new clinical results and emphasizing the need for well-designed preclinical models to develop effective treatments.

research Chemotherapy-Induced Alopecia

103 citations , December 2011 in “Journal of the American Academy of Dermatology”

This review discusses current knowledge and management strategies for chemotherapy-induced alopecia, highlighting the need for better research prioritization and providing patient support materials, but reports no new clinical results.

research Treatment of Chemotherapy-Induced Alopecia

64 citations , July 2011 in “Dermatologic Therapy”

This review discusses treatments for chemotherapy-induced alopecia, highlighting scalp cooling for hair loss prevention and 2% topical minoxidil for regrowth acceleration as effective options, but reports a need for more rigorous trials to validate promising new therapies.

research Permanent Alopecia After Systemic Chemotherapy: A Clinicopathological Study of 10 Cases

57 citations , March 2011 in “The American Journal of Dermatopathology”

This study found that permanent alopecia can occur after certain chemotherapy treatments and presents as nonscarring hair loss similar to androgenetic alopecia, with specific histological features that could be misdiagnosed without proper clinicopathological correlation.

research Permanent Chemotherapy-Induced Alopecia: Case Report and Review of the Literature

67 citations , May 2010 in “Journal of The American Academy of Dermatology”

This article discusses a unique case of permanent chemotherapy-induced alopecia in a patient receiving chemotherapy for breast cancer, characterized by a distinctive histologic finding and excludes bone marrow transplantation, but reports no new clinical results.

research Cicatricial Alopecia Secondary to Radiation Therapy: Case Report and Review of the Literature

37 citations , February 2008 in “PubMed”

This article reviews radiation-induced cicatricial alopecia and suggests that controlling radiation dose depth could potentially prevent this condition.

research Six Cases of Permanent Alopecia After Various Conditioning Regimens Commonly Used in Hematopoietic Stem Cell Transplantation

40 citations , September 2007 in “Bone marrow transplantation”

Certain chemotherapy drugs can cause permanent hair loss in stem cell transplant patients.

research Permanent Alopecia Following Chemotherapy and Bone Marrow Transplantation

63 citations , May 2000 in “Australasian Journal of Dermatology”

This case study reported a 23-year-old woman with chronic myeloid leukemia who developed permanent hair loss after chemotherapy and did not respond to topical minoxidil treatment.